Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of 29.18 billion. The enterprise value is 30.90 billion.
Market Cap | 29.18B |
Enterprise Value | 30.90B |
Important Dates
The next estimated earnings date is Thursday, May 8, 2025.
Earnings Date | May 8, 2025 |
Ex-Dividend Date | Apr 7, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 346.72M |
Valuation Ratios
The trailing PE ratio is 92.17.
PE Ratio | 92.17 |
Forward PE | n/a |
PS Ratio | 7.35 |
PB Ratio | 2.52 |
P/TBV Ratio | 24.47 |
P/FCF Ratio | 41.35 |
P/OCF Ratio | 27.64 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.21, with an EV/FCF ratio of 43.79.
EV / Earnings | 97.61 |
EV / Sales | 7.09 |
EV / EBITDA | 25.21 |
EV / EBIT | 32.39 |
EV / FCF | 43.79 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.73 |
Quick Ratio | 1.05 |
Debt / Equity | 0.16 |
Debt / EBITDA | 1.66 |
Debt / FCF | 2.64 |
Interest Coverage | 10.48 |
Financial Efficiency
Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.
Return on Equity (ROE) | 4.67% |
Return on Assets (ROA) | 5.54% |
Return on Invested Capital (ROIC) | 6.61% |
Return on Capital Employed (ROCE) | 5.97% |
Revenue Per Employee | 375,056 |
Profits Per Employee | 29,918 |
Employee Count | 10,582 |
Asset Turnover | 0.40 |
Inventory Turnover | 3.05 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.99% in the last 52 weeks. The beta is 0.56, so Novonesis's price volatility has been lower than the market average.
Beta (5Y) | 0.56 |
52-Week Price Change | +12.99% |
50-Day Moving Average | 59.18 |
200-Day Moving Average | 61.46 |
Relative Strength Index (RSI) | 58.45 |
Average Volume (20 Days) | 66,724 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of 3.97 billion and earned 316.60 million in profits. Earnings per share was 1.14.
Revenue | 3.97B |
Gross Profit | 2.06B |
Operating Income | 872.66M |
Pretax Income | 431.83M |
Net Income | 316.60M |
EBITDA | 1.12B |
EBIT | 872.66M |
Earnings Per Share (EPS) | 1.14 |
Balance Sheet
The company has 289.89 million in cash and 1.86 billion in debt, giving a net cash position of -1.57 billion.
Cash & Cash Equivalents | 289.89M |
Total Debt | 1.86B |
Net Cash | -1.57B |
Net Cash Per Share | n/a |
Equity (Book Value) | 11.57B |
Book Value Per Share | 41.64 |
Working Capital | 819.03M |
Cash Flow
In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -350.24 million, giving a free cash flow of 705.66 million.
Operating Cash Flow | 1.06B |
Capital Expenditures | -350.24M |
Free Cash Flow | 705.66M |
FCF Per Share | n/a |
Margins
Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.
Gross Margin | 52.00% |
Operating Margin | 21.99% |
Pretax Margin | 10.88% |
Profit Margin | 7.98% |
EBITDA Margin | 28.23% |
EBIT Margin | 21.99% |
FCF Margin | 17.78% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 0.87%.
Dividend Per Share | 0.54 |
Dividend Yield | 0.87% |
Dividend Growth (YoY) | -4.48% |
Years of Dividend Growth | n/a |
Payout Ratio | 81.65% |
Buyback Yield | -0.64% |
Shareholder Yield | 0.23% |
Earnings Yield | 1.08% |
FCF Yield | 2.42% |
Stock Splits
The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.
Last Split Date | Dec 9, 2011 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Novonesis has an Altman Z-Score of 5.27.
Altman Z-Score | 5.27 |
Piotroski F-Score | n/a |